Skip to main content
SpringerLink
Log in

Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Slany RK . The molecular biology of mixed lineage leukemia. Haematologica 2009; 94: 984–993.

    Article  CAS  Google Scholar 

  2. Xu XQ, Wang JM, Lu SQ, Chen L, Yang JM, Zhang WP et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica 2009; 94: 919–927.

    Article  Google Scholar 

  3. Yan L, Ping N, Zhu M, Sun A, Xue Y, Ruan C et al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica 2012; 97: 1708–1712.

    Article  Google Scholar 

  4. Liu QF, Fan ZP, Wu MQ, Sun J, Wu XL, Xu D et al. Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens. Ann Hematol 2013; 92: 679–687.

    Article  CAS  Google Scholar 

  5. Guo M, Hu KX, Yu CL, Sun QY, Qiao JH, Wang DH et al. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood 2011; 117: 936–941.

    Article  CAS  Google Scholar 

  6. Polak J, Hajkova H, Maalaufova-Soukupova J, Markova J, Salek C, Schwarz J et al. Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression. Exp Ther Med 2012; 3: 129–133.

    Article  CAS  Google Scholar 

  7. Guo M, Hu KX, Liu GX, Yu CL, Qiao JH, Sun QY et al. HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up. J Clin Oncol 2012; 30: 4084–4090.

    Article  Google Scholar 

  8. Porter DL, Connors JM, Van Deerlin VM, Duffy KM, McGarigle C, Saidman SL et al. Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies. J Clin Oncol 1999; 17: 1234.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, 303rd Hospital of the Peoplès Liberation Army, Nanning, China

    Y-S Chen, X-J Kong, X-H Zhang & X-L Yin

Authors
  1. Y-S Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X-J Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X-H Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X-L Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to X-L Yin.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, YS., Kong, XJ., Zhang, XH. et al. Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation. Bone Marrow Transplant 49, 984–985 (2014). https://doi.org/10.1038/bmt.2014.74

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.74

  • Springer Nature Limited

This article is cited by

Search

Navigation